Biostime 1112

Re: Biostime 1112

Postby winston » Thu Aug 28, 2014 2:09 pm

not vested

Research Report>BIOSTIME (01112.HK) downgraded to Underperform, target cut to $30 - HSBC

According to the latest research report by HSBC, the 1H profit of BIOSTIME (01112.HK) was disappointing.

Core profit declined 32% yearly to RMB312 million, missing the bank's projection.

HSBC pointed out although the VIP membership and point of sales had increased significantly in 1H, sales only moved up by 6%, showing the efficiency of point of sales had deteriorated substantially, coupled with competition brought by other online retailers.

Target price was slashed from $65 to $30.

2014-2016 earnings estimates were trimmed by 27-34%. Rating was downgraded from Overweight to Underperform. ~

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118526
Joined: Wed May 07, 2008 9:28 am

Re: Biostime 1112

Postby winston » Thu Aug 28, 2014 2:11 pm

not vested

<Research Report>BIOSTIME (01112.HK) downgraded to Underperform, target cut to $30.8 - Stanchart
Aug 21, 2014

Standard Chartered Bank finds BIOSTIME (01112.HK)'s outlook dim and decided to downgrade its rating from Outperform to Underperform with target price reduced from $48.88 to $30.8, indicating 17% downside from its current price.

The bank stated that the company's interim results was disappointing, which proved its negative view towards its prospect.

It also substantially lowered the company's 2014-2015 EPS forecasts by 29.1% and 36.5% respectively; meanwhile, the gross profit estimate was also trimmed down to reflect the decline in average selling price due to the promotional activities, rising raw material prices and the change of product portfolio.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118526
Joined: Wed May 07, 2008 9:28 am

Re: Biostime 1112

Postby winston » Mon Nov 16, 2015 11:17 am

not vested

BIOSTIME (01112.HK) Once Plummets 20%; Expects 2015 Earnings to Cut 90%

BIOSTIME (01112.HK) issued a profit warning, expecting to record a year-on-year plunge of 90% in profit for 2015 which was due to the sales of the newly launched SN-2 PLUS Balanced Formula series, impacted by the longer time needed to clear away the previous Biostime branded infant formulas series inventories; and the non-recurring expense incurred in connection with the integration of the businesses.

The stock further sank below the 50-day MA ($15.18) with a loss of up to 20%.

It last traded at $13.6, down 14% after hitting $12.68, on surging volume of 8.31 million shares.

BIOSTIME's peers including blue-chip MENGNIU DAIRY (02319.HK) and YASHILI INT'L (01230.HK) also performed weakly, whose share prices last recorded at $13.24 and $1.99 respectively, down nearly 3% and 4%.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118526
Joined: Wed May 07, 2008 9:28 am

Previous

Return to A to B

Who is online

Users browsing this forum: No registered users and 9 guests